Sarah K Medrek1, Christina C Kao1, Danny H Yang1, Nicola A Hanania1, Amit D Parulekar2. 1. Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Tex. 2. Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Tex. Electronic address: paruleka@bcm.edu.
Abstract
BACKGROUND: Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. OBJECTIVE: The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. METHODS: A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. RESULTS: Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3%) had fungal sensitization, 117 (38.1%) had nonfungal sensitization, and 137 (44.6%) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66% for fungal vs 29% for nonfungal, P < .001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P < .001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2%, 3.7%, and 3.4%, respectively, for ICU admission, P = .02; 11.3%, 1.5%, and 0.9%, respectively, for ventilation, P < .001). CONCLUSIONS: Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.
BACKGROUND: Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. OBJECTIVE: The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. METHODS: A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. RESULTS: Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3%) had fungal sensitization, 117 (38.1%) had nonfungal sensitization, and 137 (44.6%) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66% for fungal vs 29% for nonfungal, P < .001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P < .001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2%, 3.7%, and 3.4%, respectively, for ICU admission, P = .02; 11.3%, 1.5%, and 0.9%, respectively, for ventilation, P < .001). CONCLUSIONS: Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.
Authors: Matthew S Godwin; Kristen M Reeder; Jaleesa M Garth; Jonathan P Blackburn; MaryJane Jones; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele Journal: JCI Insight Date: 2019-11-01
Authors: Jaleesa M Garth; Joseph J Mackel; Kristen M Reeder; Jonathan P Blackburn; Chad W Dunaway; Zhihong Yu; Sadis Matalon; Lori Fitz; Chad Steele Journal: Infect Immun Date: 2018-06-21 Impact factor: 3.441
Authors: Matthew S Godwin; MaryJane Jones; Jonathan P Blackburn; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-12-16 Impact factor: 5.464
Authors: Joseph J Mackel; Jaleesa M Garth; MaryJane Jones; Diandra A Ellis; Jonathan P Blackburn; Zhihong Yu; Sadis Matalon; Miranda Curtiss; Frances E Lund; Annette T Hastie; Deborah A Meyers; Chad Steele Journal: Am J Physiol Lung Cell Mol Physiol Date: 2021-02-03 Impact factor: 6.011
Authors: Ken Junyang Goh; Anthony Chau Ang Yii; Therese Sophie Lapperre; Adrian Kw Chan; Fook Tim Chew; Sanjay H Chotirmall; Mariko Siyue Koh Journal: J Asthma Allergy Date: 2017-04-21
Authors: Matthew A Tyler; Kent Lam; Michael J Marino; William C Yao; Isaac Schmale; Martin J Citardi; Amber U Luong Journal: Int Forum Allergy Rhinol Date: 2021-06-02 Impact factor: 3.858